PROQR THERAPEUTICS N.V. - Daily - Technical analysis published on 09/09/2019 (GMT)
- 318
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Strongly bearish
De fond:
Strongly bearish
Technical indicators
33%
39%
28%
My opinion
Bearish under 9.39 USD
My targets
6.52 USD (-10.93%)
3.77 USD (-48.50%)
My analysis
The bearish trend is currently very strong for PROQR THERAPEUTICS N.V.. As long as the price remains below the resistance at 9.39 USD, you could try to take advantage of the bearish rally. The first bearish objective is located at 6.52 USD. The bearish momentum would be revived by a break in this support. Sellers would then use the next support located at 3.77 USD as an objective. Be careful, given the powerful bearish rally underway, excesses could lead to a short-term rebound. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The PROQR THERAPEUTICS N.V. rating is 7.32 USD. On the day, this instrument gained +6.09% with the lowest point at 6.87 USD and the highest point at 7.59 USD. The deviation from the price is +6.55% for the low point and -3.56% for the high point.6.87
7.59
7.32
The Central Gaps scanner detects a bullish opening marking the presence of sellers ahead of buyers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bearish opening
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new LOW record (1 year)
Type : Bearish
Timeframe : Weekly
Near a new LOW record (1st january)
Type : Bearish
Timeframe : Weekly
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
A technical analysis in Daily of this PROQR THERAPEUTICS N.V. chart shows a sharp bearish trend. 92.86% of the signals given by moving averages are bearish. This strongly bearish trend is supported by the strong bearish signals given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : Daily
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S2
S1
R1
R2
R3
Price
| S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|
| ProTrendLines | 3.77 | 6.52 | 7.32 | 9.39 | 13.08 | 15.51 |
| Change (%) | -48.50% | -10.93% | - | +28.28% | +78.69% | +111.89% |
| Change | -3.55 | -0.80 | - | +2.07 | +5.76 | +8.19 |
| Level | Minor | Major | - | Intermediate | Intermediate | Major |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 6.40 | 6.57 | 6.73 | 6.90 | 7.06 | 7.23 | 7.39 |
| Camarilla | 6.81 | 6.84 | 6.87 | 6.90 | 6.93 | 6.96 | 6.99 |
| Woodie | 6.41 | 6.57 | 6.74 | 6.90 | 7.07 | 7.23 | 7.40 |
| Fibonacci | 6.57 | 6.69 | 6.77 | 6.90 | 7.02 | 7.10 | 7.23 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 5.74 | 6.38 | 6.79 | 7.43 | 7.84 | 8.48 | 8.89 |
| Camarilla | 6.90 | 7.00 | 7.09 | 7.19 | 7.29 | 7.38 | 7.48 |
| Woodie | 5.62 | 6.32 | 6.67 | 7.37 | 7.72 | 8.42 | 8.77 |
| Fibonacci | 6.38 | 6.78 | 7.03 | 7.43 | 7.83 | 8.08 | 8.48 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 3.79 | 5.41 | 6.30 | 7.92 | 8.81 | 10.44 | 11.33 |
| Camarilla | 6.50 | 6.73 | 6.96 | 7.19 | 7.42 | 7.65 | 7.88 |
| Woodie | 3.42 | 5.22 | 5.93 | 7.74 | 8.45 | 10.25 | 10.96 |
| Fibonacci | 5.41 | 6.37 | 6.96 | 7.92 | 8.88 | 9.48 | 10.44 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 39.74 | |
| MACD (12,26,9): | -0.4700 | |
| Directional Movement: | -1.45 | |
| AROON (14): | -78.57 | |
| DEMA (21): | 7.13 | |
| Parabolic SAR (0,02-0,02-0,2): | 6.73 | |
| Elder Ray (13): | -0.25 | |
| Super Trend (3,10): | 8.24 | |
| Zig ZAG (10): | 7.32 | |
| VORTEX (21): | 0.8200 | |
| Stochastique (14,3,5): | 14.09 | |
| TEMA (21): | 7.01 | |
| Williams %R (14): | -72.43 | |
| Chande Momentum Oscillator (20): | -1.03 | |
| Repulse (5,40,3): | 0.7600 | |
| ROCnROLL: | 2 | |
| TRIX (15,9): | -0.6500 | |
| Courbe Coppock: | 30.63 |
| MA7: | 7.15 | |
| MA20: | 7.88 | |
| MA50: | 8.42 | |
| MA100: | 9.86 | |
| MAexp7: | 7.23 | |
| MAexp20: | 7.72 | |
| MAexp50: | 8.58 | |
| MAexp100: | 9.86 | |
| Price / MA7: | +2.38% | |
| Price / MA20: | -7.11% | |
| Price / MA50: | -13.06% | |
| Price / MA100: | -25.76% | |
| Price / MAexp7: | +1.24% | |
| Price / MAexp20: | -5.18% | |
| Price / MAexp50: | -14.69% | |
| Price / MAexp100: | -25.76% |
News
The last news published on PROQR THERAPEUTICS N.V. at the time of the generation of this analysis was as follows:
- Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications
- ProQR Announces Results for the Third Quarter of 2016
- ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis PROQR THERAPEUTICS N.V. - Daily